Can Antiphospholipid Syndrome Cause Hair Loss?
No, antiphospholipid syndrome (APS) does not directly cause hair loss as a recognized clinical manifestation of the disease. The provided evidence extensively documents the cutaneous and systemic manifestations of APS, and hair loss is notably absent from these comprehensive descriptions.
What APS Actually Causes
The well-established cutaneous manifestations of APS include 1, 2, 3:
- Livedo reticularis (most common skin finding)
- Cutaneous necrosis and ulceration due to dermal thrombosis
- Thrombophlebitis
- Purpura and ecchymoses
- Painful skin nodules
- Subungual splinter hemorrhages
- Necrotizing vasculitis (though noninflammatory vascular thrombosis is more typical)
In a large cohort study of 1,000 APS patients, the documented manifestations included thrombotic events, pregnancy complications, thrombocytopenia, livedo reticularis, cardiac valve disease, and neurological complications—but hair loss was not reported 3.
Important Clinical Context
The evidence you're reviewing primarily addresses alopecia areata, which is an entirely different autoimmune condition characterized by patchy hair loss 4. While the guidelines note that alopecia areata has associations with "other autoimmune diseases" 4, this does not establish a causal link between APS and hair loss.
Key Distinction:
- Alopecia areata is a T-lymphocyte mediated autoimmune attack on hair follicles
- APS is a thrombophilic disorder causing vascular thrombosis through antiphospholipid antibodies
These are mechanistically distinct processes.
Clinical Pitfall to Avoid
If a patient with APS presents with hair loss, consider:
- Coincidental alopecia areata (both are autoimmune conditions that can coexist)
- Medication side effects (anticoagulants like warfarin can rarely cause hair loss)
- Telogen effluvium from systemic illness or stress
- Other unrelated causes of alopecia
Do not attribute the hair loss to APS itself, as this is not a recognized manifestation of the syndrome based on extensive clinical experience and large cohort studies 1, 2, 3.